Year |
Citation |
Score |
2016 |
Saumonneau A, Champion E, Peltier-Pain P, Molnar-Gabor D, Hendrickx J, Tran V, Hederos M, Dekany G, Tellier C. Design of an α-L-transfucosidase for the synthesis of fucosylated HMOs. Glycobiology. 26: 261-9. PMID 26582607 DOI: 10.1093/glycob/cwv099 |
0.355 |
|
2013 |
Daudé D, Champion E, Morel S, Guieysse D, Remaud-Siméon M, André I. Probing substrate promiscuity of amylosucrase from neisseria polysaccharea Chemcatchem. 5: 2288-2295. DOI: 10.1002/Cctc.201300012 |
0.473 |
|
2012 |
Champion E, Guérin F, Moulis C, Barbe S, Tran TH, Morel S, Descroix K, Monsan P, Mourey L, Mulard LA, Tranier S, Remaud-Siméon M, André I. Applying pairwise combinations of amino acid mutations for sorting out highly efficient glucosylation tools for chemo-enzymatic synthesis of bacterial oligosaccharides. Journal of the American Chemical Society. 134: 18677-88. PMID 23072374 DOI: 10.1021/Ja306845B |
0.601 |
|
2010 |
Champion E, Moulis C, Morel S, Mulard LA, Monsan P, Remaud-Siméon M, André I. A pH-Based High-Throughput Screening of Sucrose-Utilizing Transglucosidases for the Development of Enzymatic Glucosylation Tools Chemcatchem. 2: 969-975. DOI: 10.1002/Cctc.201000111 |
0.532 |
|
2009 |
Champion E, Remaud-Simeon M, Skov LK, Kastrup JS, Gajhede M, Mirza O. The apo structure of sucrose hydrolase from Xanthomonas campestris pv. campestris shows an open active-site groove. Acta Crystallographica. Section D, Biological Crystallography. 65: 1309-14. PMID 19966417 DOI: 10.1107/S0907444909040311 |
0.49 |
|
2009 |
Champion E, André I, Moulis C, Boutet J, Descroix K, Morel S, Monsan P, Mulard LA, Remaud-Siméon M. Design of alpha-transglucosidases of controlled specificity for programmed chemoenzymatic synthesis of antigenic oligosaccharides. Journal of the American Chemical Society. 131: 7379-89. PMID 19432472 DOI: 10.1021/Ja900183H |
0.566 |
|
2009 |
Champion E, Andre I, Mulard LA, Monsan P, Remaud-Simeon M, Morel S. Synthesis of l-rhamnose and n-acetyl-d-glucosamine derivatives entering in the composition of bacterial polysaccharides by use of glucansucrases Journal of Carbohydrate Chemistry. 28: 142-160. DOI: 10.1080/07328300902755796 |
0.458 |
|
Low-probability matches (unlikely to be authored by this person) |
2013 |
Böttcher S, Hederos M, Champion E, Dékány G, Thiem J. Novel efficient routes to indoxyl glycosides for monitoring glycosidase activities. Organic Letters. 15: 3766-9. PMID 23829284 DOI: 10.1021/ol401710a |
0.295 |
|
1992 |
Labelle M, Prasit P, Belley M, Blouin M, Champion E, Charette L, DeLuca JG, Dufresne C, Frenette R, Gauthier JY, Grimm E, Grossman SJ, Guay D, Herold EG, Jones TR, et al. The discovery of a new structural class of potent orally active leukotriene D4 antagonists Bioorganic and Medicinal Chemistry Letters. 2: 1141-1146. DOI: 10.1016/S0960-894X(00)80635-6 |
0.267 |
|
1994 |
Labelle M, Belley M, Champion E, Gordon R, Hoogsteen K, Jones TR, Leblanc Y, Lord A, McAuliffe M, McFarlane C, Masson P, Metters KM, Nicoll-Griffith D, Ouimet N, Piechuta H, et al. The discovery of L-699,392, a novel potent and orally active leukotriene D4 receptor antagonist Bioorganic and Medicinal Chemistry Letters. 4: 463-468. DOI: 10.1016/0960-894X(94)80017-0 |
0.259 |
|
1990 |
Gauthier JY, Jones T, Champion E, Charette L, Dehaven R, Ford-Hutchinson AW, Hoogsteen K, Lord A, Masson P, Piechuta H. Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonist. Journal of Medicinal Chemistry. 33: 2841-5. PMID 2170650 DOI: 10.1021/JM00172A025 |
0.252 |
|
1986 |
Young RN, Bélanger P, Champion E, DeHaven RN, Denis D, Ford-Hutchinson AW, Fortin R, Frenette R, Gauthier JY, Gillard J, Guindon Y, Jones TR, Kakushima M, Masson P, Maycock A, et al. Design and synthesis of sodium (βR*,γS*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy) propyl]thio]-γ-hydroxy-β-methyl-benzenebutanoate: A novel, selective, and orally active receptor antagonist of leukotriene D4 [2] Journal of Medicinal Chemistry. 29: 1573-1576. PMID 3746809 DOI: 10.1021/JM00159A003 |
0.251 |
|
1986 |
Jones TR, Guindon Y, Young R, Champion E, Charette L, Denis D, Ethier D, Hamel R, Ford-Hutchinson AW, Fortin R. L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 64: 1535-42. PMID 3030524 DOI: 10.1139/Y86-258 |
0.224 |
|
1986 |
Young RN, Champion E, Gauthier JY, Jones TR, Leger S, Zamboni R. Stereoselective synthesis of some acetylenic analogues of leukotrienes A and D Tetrahedron Letters. 27: 539-542. DOI: 10.1016/S0040-4039(00)84034-4 |
0.216 |
|
2010 |
LABELLE M, BELLEY M, CHAMPION E, GORDON R, HOOGSTEEN K, JONES TR, LEBLANC Y, LORD A, MCAULIFFE M, MCFARLANE C, MASSON P, METTERS KM, NICOLL-GRIFFITH D, OUIMET N, PIECHUTA H, et al. ChemInform Abstract: The Discovery of L-699,392, a Novel Potent and Orally Active Leukotriene D4 Receptor Antagonist. Cheminform. 25: no-no. DOI: 10.1002/CHIN.199431162 |
0.21 |
|
1986 |
Jones TR, Young R, Champion E, Charette L, Denis D, Ford-Hutchinson AW, Frenette R, Gauthier JY, Guindon Y, Kakushima M. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Canadian Journal of Physiology and Pharmacology. 64: 1068-75. PMID 3024787 DOI: 10.1139/Y86-183 |
0.205 |
|
1987 |
Hall RA, Gillard J, Guindon Y, Letts G, Champion E, Ethier D, Evans J, Ford-Hutchinson AW, Fortin R, Jones TR. Pharmacology of L-655,240 (3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl]2,2-dimethylpro pan oic acid); a potent, selective thromboxane/prostaglandin endoperoxide antagonist. European Journal of Pharmacology. 135: 193-201. PMID 3582493 DOI: 10.1016/0014-2999(87)90611-X |
0.189 |
|
1989 |
Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier JY, Leger S, Masson P. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 67: 17-28. PMID 2540892 DOI: 10.1139/Y89-004 |
0.188 |
|
2020 |
Eimerman P, Jeddeloh J, Champion E, Peponnet C, Gariel S, Godron X, Ybert T, Ashworth R, Knudtson K. Development of a simple and versatile enzymatic DNA synthesis system that enables accurate, fast, and long oligos on demand. Journal of Biomolecular Techniques : Jbt. 31: S10. PMID 32831690 |
0.185 |
|
1992 |
Zamboni R, Belley M, Champion E, Charette L, DeHaven R, Frenette R, Gauthier JY, Jones TR, Leger S, Masson P. Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid. Journal of Medicinal Chemistry. 35: 3832-44. PMID 1331447 DOI: 10.1021/Jm00099A011 |
0.184 |
|
1995 |
Jones TR, Labelle M, Belley M, Champion E, Charette L, Evans J, Ford-Hutchinson AW, Gauthier JY, Lord A, Masson P. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 73: 191-201. PMID 7621356 DOI: 10.1139/Y95-028 |
0.179 |
|
1986 |
YOUNG RN, CHAMPION E, GAUTHIER JY, JONES TR, LEGER S, ZAMBONI R. ChemInform Abstract: Stereoselective Synthesis of Some Acetylenic Analogues of Leukotrienes A and D′. Chemischer Informationsdienst. 17. DOI: 10.1002/chin.198623352 |
0.162 |
|
1993 |
Foulon DM, Champion E, Masson P, Rodger IW, Jones TR. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs. The American Review of Respiratory Disease. 148: 915-21. PMID 7692776 DOI: 10.1164/AJRCCM/148.4_PT_1.915 |
0.116 |
|
1991 |
Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Gauthier JY, Leger S, Lord A, Masson P. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571. Canadian Journal of Physiology and Pharmacology. 69: 1847-54. PMID 1666333 DOI: 10.1139/Y91-273 |
0.113 |
|
Hide low-probability matches. |